- Home
- MLAB vs CURR Comparison
MLAB vs CURR Comparison
Compare MLAB & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLAB | CURR |
|---|---|---|
| Founded | 1982 | 2013 |
| Country | United States | Singapore |
| Employees | N/A | 293 |
| Industry | Industrial Machinery/Components | Business Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.0M | 500.8M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | MLAB | CURR |
|---|---|---|
| Price | $98.41 | $3.07 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $94.00 | N/A |
| AVG Volume (30 Days) | ★ 207.3K | 152.3K |
| Earning Date | 05-27-2026 | 05-19-2026 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | ★ 436.11 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $5.41 | $14.56 |
| P/E Ratio | $82.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $59.63 | $0.36 |
| 52 Week High | $113.99 | $4.73 |
Technical Indicators
Market Signals| Indicator | MLAB | CURR |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 48.98 |
| Support Level | $94.01 | $2.75 |
| Resistance Level | $97.56 | $3.71 |
| Average True Range (ATR) | 5.56 | 0.32 |
| MACD | -1.13 | -0.01 |
| Stochastic Oscillator | 2.73 | 40.28 |
Price Performance
Historical ComparisonAbout MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.